Shea Calhoun, CRNP

Shea Calhoun practices at Gut Endo, LLC in Dothan, Alabama.

Shea Calhoun's NPI, 1891861290, was assigned on November 28, 2006. Shea Calhoun holds Alabama license 61079.

Shea Calhoun's primary practice is Gut Endo, LLC, at 265 Medical Park Blvd, Dothan, AL 36301 in Houston County. The practice phone is (334) 836-1212.

Shea Calhoun's primary practice is Gut Endo, LLC in Dothan, Alabama. The medical group on file is Digestive Health Specialists. Dmand AI also links Shea Calhoun to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shea Calhoun practices. Vendor and product names are available with a free account.

Nurse practitioner is Shea Calhoun's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Shea Calhoun is licensed in Alabama.

Dmand AI lists acute gastroduodenitis, chronic diabetes, chronic indigestion, gastroenteritis, high cholesterol and underactive thyroid among the conditions Shea Calhoun treats.

CMS data shows 577 Medicare services from Shea Calhoun across 3 procedure codes in 2024, for 413 Medicare patients. Medicare paid $34,934 for them. Every service was in an office.

CMS counts 413 Medicare patients who saw Shea Calhoun in 2024. The largest group is 65 to 74, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Shea Calhoun's median patient age at 67, with 63% women.

In 2024, Shea Calhoun wrote 92 Medicare Part D claims for 89 patients. 33% of them were for generic drugs. CMS names the drug for 79 of them, across 3 drugs with 11 or more claims each, at $7,956 in total drug cost.

Shea Calhoun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 295 general payments to Shea Calhoun from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,167.